Summary by Moomoo AI
Kangfang Biotechnology (Cayman) Co., Ltd. (“Kangfang Biotech”) issued a notice on 8 April 2024 informing that the communications of non-registered shareholders will be fully electronic. This is in accordance with Section 2.07A of the Securities Listing Rules of the Hong Kong Stock Exchange Limited and the paperless listing mechanism effective from 31 December 2023. Corporate communications include Directors' Reports, Annual Accounts, Audit Reports, Interim Reports, Notice of Meeting, Listing Documents, Circulars and Appointment Forms, etc. Printed copies of future company newsletters will no longer be available. Shareholders should proactively visit the Kangfang Biome official website or disclosure website. Shareholders should submit an application to the Hong Kong Central Securities Registration Office Limited for printed communications and ensure that their request is updated within a period of one year's validity.